| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Mercuric Chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPATA6L mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Mercuric Chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPATA6L mRNA" | 27188386 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of SPATA6L gene | 27153756 |
| D000535 | Aluminum | [APP protein modified form binds to Aluminum] which results in decreased expression of SPATA6L mRNA | 21298039 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of SPATA6L mRNA | 25181051 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased methylation of SPATA6L promoter | 22457795 |
| C069837 | fullerene C60 | fullerene C60 results in decreased expression of SPATA6L mRNA | 19167457 |
| D008627 | Mercuric Chloride | "[NOG protein co-treated with Mercuric Chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPATA6L mRNA" | 27188386 |
| D008694 | Methamphetamine | [Methamphetamine co-treated with SCH 23390] results in decreased expression of SPATA6L mRNA | 19564919 |
| D008694 | Methamphetamine | Methamphetamine results in decreased expression of SPATA6L mRNA | 19564919 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of SPATA6L mRNA | 26011545 |
| D009532 | Nickel | Nickel results in decreased expression of SPATA6L mRNA | 24768652|2558310 |
| C534628 | SCH 23390 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of SPATA6L mRNA | 19564919 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of SPATA6L mRNA | 25895662 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in increased expression of SPATA6L mRNA" | 26743178 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in increased expression of SPATA6L mRNA" | 26179874 |
| D014520 | Urethane | Urethane results in decreased expression of SPATA6L mRNA | 28818685 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of SPATA6L mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of SPATA6L mRNA | 28001369 |